We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Wireless Sensor Monitors Pressure During Endovascular Repair

By HospiMedica staff writers
Posted on 19 Mar 2007
Placement of a wireless pressure sensor during endovascular repair (EVAR) of an abdominal aortic aneurysm is effective in monitoring pulse pressure in the aneurysmal sac, according to results of a new study.

Researchers at the Jikei University School of Medicine (Tokyo, Japan) conducted the acute pressure measurement to confirm an aneurysm sac exclusion (APEX) clinical trial that included 76 patients at 12 sites. More...
The aneurysms were being treated with a bifurcated, modular, endovascular stent graft, and most of the procedures were performed via bilateral femoral cutdowns. An EndoSure sensor was inserted into the aneurysm before the endograft, and pressure was measured at different steps of the repair procedure. The mean estimated blood loss during the aneurysm repairs was 471 ml, and operative time averaged 205 minutes.

At the end of the procedure, pressure in the sealed-off aneurysmal sac decreased by 46%, denoting operative success. The investigators observed close agreement between pressure measured by the EndoSure sensor and angiography. The sensitivity for detecting endoleaks, indicating the incomplete exclusion from the main circulation, was 93.9% and specificity was 80%. During the next 30 days, there were no adverse events attributed to the sensor and no evidence of device migration. At 30-day follow-up, sensor signal was detected in 97% of patients. The study was reported in the February 2007 issue of the Journal of Vascular Surgery.

"Implantation of the wireless pressure sensor is safe, and remote aneurysm sac pressure sensing is feasible. It was a valuable guide in evaluating the completeness of the EVAR procedure. Long-term study will be needed to prove its efficacy for postoperative surveillance,” concluded lead author Dr. Takao Ohki and colleagues.

The EndoSure sensor is a product of CardioMEMS (Atlanta, GA, USA). The 30 x 5 x 1.5 mm sensor contains no battery and is powered externally by a radio-frequency (RF) generator. The sensors are extremely stable, operate over the full physiologic range of pressures, and have a resolution of 1 mm Hg. A change in pressure alters the resonant frequency of the sensor, which is monitored by an antenna placed on the patient's abdomen.



Related Links:
Jikei University School of Medicine
CardioMEMS

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.